Default company panoramic image
Logo

APSIS Therapeutics LTD

APSIS Therapeutics, Ltd. is a biotech company discovering therapeutic nucleosides and nucleotides against viral infections and cancers.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Albany, NY, USA
  • Currency USD
  • Founded March 2010
  • Employees 2
  • Website apsisglobal.com

Company Summary

With liver diseases, HIV/AIDS and cancers as primary therapeutic areas, we develop product pipelines of new anti(retro)viral/anticancer agents based on high throughput screening (HTS) of our molecule library of nucleosides and nucleotides by cell-free enzymatic assays of corresponding nucleotide triphosphates, on technologies of nucleotide prodrugs and on selective targeting viral genomes to cure chronic viral diseases. http://www.apsisglobal.com

Team

  • Default avatar
    Minghong Zhong
    CEO

    Dr. Zhong has twelve years’ experience in nucleoside and nucleotide chemistry. His expertise in modern organic synthesis, medicinal chemistry, and biochemistry is an important intellectual asset to this company. Dr. Zhong did his Ph.D.research with Dr. Morris J. Robins. He worked with Dr. Scott A. Strobel as a postdoctoral researcher on RNA Biochemistry at Yale, and later on antiviral nucleosides with Dr. Victor E. Marquez at NCI.